Amy Weintrob

7k citations
120 papers · 5.7k · 1 hit paper · h-index 41

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • HIV Research and Treatment 31
    • HIV/AIDS Research and Interventions 20
    • COVID-19 Clinical Research Studies 12
    • Antifungal resistance and susceptibility 10

Amy Weintrob

115 papers receiving 5.5k citations

Amy Weintrob's Hit Papers

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial 2022 · 161 citations
1610+1+2Years since publication50100150

Peers

Amy Weintrob
Comparison fields: 5 of 120
  • Virology 1.3k
  • Infectious Diseases 1.5k
  • Emergency Medicine 629
  • Molecular Medicine 327
  • Applied Microbiology and Biotechnology 105
Replace Annalisa Saracino with:
Annalisa Saracino Italy
Vicenç Falcó Spain
Robert C. Kalayjian United States
Carlos Roberto Brites Brazil
Anuradha Ganesan United States
David Nadal Switzerland
Arthur Edward Brown United States
Sheldon H. Landesman United States
Lucia Taramasso Italy
Sophie Matheron France
Amy Weintrob relative to Annalisa Saracino Italy Annalisa Saracino's profile →
Citations per field
00.5×2×3×3.7×
Annalisa Saracino · 1×
Citations per year

Countries citing papers authored by Amy Weintrob

Since Specialization
Citations

This map shows the geographic impact of Amy Weintrob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Weintrob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Weintrob more than expected).

Fields of papers citing papers by Amy Weintrob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Weintrob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Weintrob. The network helps show where Amy Weintrob may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Weintrob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Weintrob Line = papers co-authored together Amy Weintrob links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013325
2 2009322
3 2009252
4 2008216
5 2010207
6 2005200
7 2010166
8
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Hit paper breakdown →
2022161
9 2010150
10 2015145
11 2010127
12 2013122
13 2011119
14 2008104
15 2008103
16 2011103
17 202293
18 201086
19 201084
20 201483

About Amy Weintrob

Amy Weintrob is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Critical Care and Intensive Care Medicine, having authored 120 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (31 papers), HIV/AIDS Research and Interventions (20 papers), Hepatitis B Virus Studies (12 papers), COVID-19 Clinical Research Studies (12 papers), Antifungal resistance and susceptibility (10 papers), Trauma and Emergency Care Studies (10 papers), HIV-related health complications and treatments (7 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (1.5k citations), Emergency Medicine (629 citations), Molecular Medicine (327 citations) and Applied Microbiology and Biotechnology (105 citations). Amy Weintrob has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Brian K. Agan, Nancy F. Crum‐Cianflone, Anuradha Ganesan, Vincent C. Marconi, Robert Barthel, Michael L. Landrum, Glenn W. Wortmann, Joshua D. Hartzell, Katherine Huppler Hullsiek and Susan L. Fraser. Their work appears in journals such as Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, PLoS ONE and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact